[1] DUTRA A B,EMANUELI S L,MICHELE G D S,et al.Repositioning and development of new treatments for neurodegenerative diseases:Focus on neuroinflammation[J]. European Journal of Pharmacology,2022,919:174800. [2] MA J,WANG X X,LI N,et al.A bifunctional probe that allows dual-channel fluorescence turn-on detection of protein aggregates and hydrogen peroxide in neurodegenerative diseases[J]. Sensors and Actuators B: Chemical,2021,346:130536. [3] LI X N,HUANG L J,LAN J Q,et al.Molecular mechanisms of mitophagy and its roles in neurodegenerative diseases[J]. Pharmacological Research,2020,163:105240. [4] WANG X L,FENG S T,WANG Z Z,et al.Role of mitophagy in mitochondrial quality control:Mechanisms and potential implications for neurodegenerative diseases[J]. Pharmacological Research,2021,165:105433. [5] 杨陶然,王儒蓉.线粒体在细胞铁死亡中的作用[J].生理科学进展,2022,53(3):224-228. YANG T R,WANG R R.Role of mitochondria in cell ferroptosis[J]. Progress in Physiological Sciences,2022,53(3):224-228.(in Chinese) [6] CARLOTTA G,ESMAA B,ALBERTO D,et al.Relevance of autophagy and mitophagy dynamics and markers in neurodegenerative diseases[J]. Biomedicines,2021,9(2):149. [7] MORI M P,PENJWEINI R,KNUTSON J R,et al.Mitochondria and oxygen homeostasis[J]. The FEBS Journal,2022,289(22):6959-6968. [8] GAETANA N,GIANLUCA F,PAOLA V.Mitochondrial management of reactive oxygen species[J]. Antioxidants,2021,10(11):1824. [9] LEMASTERS J J.Selective mitochondrial autophagy,or mitophagy,as a targeted defense against oxidative stress,mitochondrial dysfunction,and aging[J]. Rejuvenation Research,2005,8(1):3-5. [10] KONSTANTINOS P,EIRINI L,NEKTARIOS T.Mechanisms of mitophagy in cellular homeostasis,physiology and pathology[J]. Nature Cell Biology,2018,20(9):1013-1022. [11] 吴繁,刘莉,金娟,等.线粒体质量控制与心血管疾病[J].国际心血管病杂志,2021,48(3):160-162. WU F,LIU L,JIN J,et al.Mitochondrial quality control and cardiovascular diseases[J]. International Journal of Cardiovascular Disease,2021,48(3):160-162.(in Chinese) [12] CUI M Y,TAMOTSU Y,SHUHEI N.Autophagy system as a potential therapeutic target for neurodegenerative diseases[J]. Neurochemistry International,2022,155:105308. [13] 张晓放,李思琦,张强,等.Parkin介导的线粒体自噬及细胞器互作机制[J].生物化学与生物物理进展,2021,48(11):1253-1259. ZHANG X F,LI S Q,ZHANG Q,et al.Parkin-mediated mitophagy and organelle contaccts[J]. Progress in Biochemistry and Biophysics,2021,48(11):1253-1259.(in Chinese) [14] HERRANZ N,GIL J.Mechanisms and functions of cellular senescence[J]. The Journal of Clinical Investigation,2018,128(4):1238-1246. [15] LI W W,LI J,BAO J K.Microautophagy:Lesser-known self-eating[J]. Cellular and Molecular Life Sciences,2012,69(7):1125-1136. [16] SUSMITA K,MARIA C A.The coming of age of chaperone-mediated autophagy[J]. Nature Reviews Molecular Cell Biology,2018,19(6):365-381. [17] LIN Q,LI S,JIANG N,et al.PINK1-Parkin pathway of mitophagy protects against contrast-induced acute kidney injury via decreasing mitochondrial ROS and NLRP3 inflammasome activation[J]. Redox Biology,2019,26:101254. [18] MIJA M,MATILDA Š,IVANA N.Dimerization of mitophagy receptor BNIP3L/NIX is essential for recruitment of autophagic machinery[J]. Autophagy,2020,17(5):1232-1243. [19] ROJANSKY R,CHA M Y,CHAN D C.Elimination of paternal mitochondria in mouse embryos occurs through autophagic degradation dependent on PARKIN and MUL1[J]. eLife,2016,5:e17896. [20] FRITSCH L E,MOORE M E,SARRAF S A,et al.Ubiquitin and receptor-dependent mitophagy pathways and their implication in neurodegeneration[J]. Journal of Molecular Biology,2020,432(8):2510-2524. [21] DEREK N,ATSUSHI T,DER-FEN S,et al.Parkin is recruited selectively to impaired mitochondria and promotes their autophagy[J]. The Journal of Cell Biology,2008,183(5):795-803. [22] CRISTINA G L,LIU Y,LAURITZEN K H,et al.PINK1 content in mitochondria is regulated by ER-associated degradation[J]. The Journal of Neuroscience,2019,39(36):7074-7085. [23] SEIRAFI M,TREMPE J F,SAUVE V,et al.Structure of Parkin reveals the mechanism of autoinhibition[J]. Acta Crystallographica,2014,70(Pt a1):C838. [24] WADE H J,ALBAN O,HEO J M.Building and decoding ubiquitin chains for mitophagy[J]. Nature Reviews Molecular Cell Biology,2018,19(2):93-108. [25] CAULFIELD T R,FIESEL F C,MOUSSAUD-LAMODIÈRE E L,et al.Phosphorylation by PINK1 releases the UBL domain and initializes the conformational opening of the E3 ubiquitin ligase Parkin[J]. PLoS Computational Biology,2014,10(11):e1003935. [26] VILLA E,PROÏCS E,PATIÑO C R,et al.Parkin-independent mitophagy controls chemotherapeutic response in cancer cells[J]. Cell Reports,2017,20(12):2846-2859. [27] RAJAT P,CHENG X T,LIN M Y,et al.Mul1 restrains Parkin-mediated mitophagy in mature neurons by maintaining ER-mitochondrial contacts[J]. Nature Communications,2019,10(1):3645. [28] DEBDATTO M,SUBHRANGSHU D,RUKMINI M,et al.RETREG1/FAM134B mediated autophagosomal degradation of AMFR/GP78 and OPA1-A dual organellar turnover mechanism[J]. Autophagy,2020,17(7):1729-1752. [29] RAYMONDE S,VERED S,FATIMAH A E,et al.The PINK1,synphilin-1 and SIAH-1 complex constitutes a novel mitophagy pathway[J]. Human Molecular Genetics,2016,25(16):3476-3490. [30] POON A,SAINI H,SETHI S,et al.The role of SQSTM1 (p62) in mitochondrial function and clearance in human cortical neurons[J]. Stem Cell Reports,2021,16(5):1276-1289. [31] MASHUN O,KOJI Y,MIYUKI S,et al.Molecular mechanisms and physiological functions of mitophagy[J]. The EMBO Journal,2021,40(3):e104705. [32] LI Y,ZHENG W,LU Y,et al.BNIP3L/NIX-mediated mitophagy:Molecular mechanisms and implications for human disease[J]. Cell Death & Disease,2021,13(1):14. [33] LEI L,DU F,GUO C,et al.Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells[J]. Nature Cell Biology,2012,14(2):177-185. [34] CHEN G,HAN Z,FENG D,et al.A regulatory signaling loop comprising the PGAM5 phosphatase and CK2 controls receptor-mediated mitophagy[J]. Molecular Cell,2014,54(3):362-377. [35] PRAHARAJ P P,NAIK P P,PANIGRAHI D P,et al.Intricate role of mitochondrial lipid in mitophagy and mitochondrial apoptosis:Its implication in cancer therapeutics[J]. Cellular and Molecular Life Sciences,2018,76(9):1641-1652. [36] CHAO H,LIN C,ZUO Q,et al.Cardiolipin-dependent mitophagy guides outcome after traumatic brain injury[J]. The Journal of Neuroscience,2019,39(10):1930-1943. [37] LOU G F,PALIKARAS K,LAUTRUP S,et al.Mitophagy and neuroprotection[J]. Trends in Molecular Medicine,2019,26(1):8-20. [38] LI B,CHEN M L,ZHU C H.Neuroinflammation in prion disease[J]. International Journal of Molecular Sciences,2021,22(4):2196. [39] 孙文珊,徐运.朊蛋白在神经系统作用机制研究进展[J].国际神经病学神经外科学杂志,2021,48(1):86-89. SUN W S,XU Y.Research advances in the mechanism of action of prion protein in the nervous system[J]. Journal of International Neurology and Neurosurgery,2021,48(1):86-89.(in Chinese) [40] SPAGNOLLI G,REQUENA J R,BIASINI E.Understanding prion structure and conversion[J]. Progress in Molecular Biology and Translational Science,2020,175:19-30. [41] O’DONOVAN C N,TOBIN D,COTTER T G.Prion protein fragment PrP-(106-126) induces apoptosis via mitochondrial disruption in human neuronal SH-SY5Y cells[J]. The Journal of Biological Chemistry,2001,276(47):43516-43523. [42] LI C,WANG D,WU W,et al.DLP1-dependent mitochondrial fragmentation and redistribution mediate prion-associated mitochondrial dysfunction and neuronal death[J]. Aging Cell,2018,17(1):e12693. [43] GAO L P,XIAO K,WU Y Z,et al.Enhanced mitophagy activity in prion infected cultured cells and prion infected experimental mice via PINK1/Parkin dependent mitophagy pathway[J]. ACS Chemical Neuroscience,2020,11(5):814-829. [44] LI J,LAI M Y,ZHANG X X,et al.PINK1-parkin-mediated neuronal mitophagy deficiency in prion disease[J]. Cell Death & Disease,2022,13(2):162. [45] LI P,FENG D,YANG D C,et al.Protective effects of anthocyanins on neurodegenerative diseases[J]. Trends in Food Science & Technology,2021,117(11):205-217. [46] KÖPKE E,TUNG Y C,SHAIKH S,et al.Microtubule-associated protein tau.Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease[J]. The Journal of Biological Chemistry,1993,268(32):24374-24384. [47] GUHA S,JOHNSON G V W,NEHRKE K.The crosstalk between pathological tau phosphorylation and mitochondrial dysfunction as a key to understanding and treating Alzheimer’s disease[J]. Molecular Neurobiology,2020,57(12):5103-5120. [48] CORSETTI V,FLORENZANO F,ATLANTE A,et al.NH2-truncated human tau induces deregulated mitophagy in neurons by aberrant recruitment of Parkin and UCHL-1:Implications in Alzheimer’s disease[J]. Human Molecular Genetics,2015,24(11):3058-3081. [49] PATRICIA M M,RICARDO G,ESTHER G,et al.Mitophagy failure in APP and tau overexpression model of Alzheimer’s disease[J]. Journal of Alzheimer’s Disease,2019,70(2):525-540. [50] JIANG X J,WU Y Q,MA R,et al.PINK1 alleviates cognitive impairments via attenuating pathological tau aggregation in a mouse model of tauopathy[J]. Frontiers in Cell and Developmental Biology,2022,9:736267. [51] FANG E F,HOU Y,PALIKARAS K,et al.Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease[J]. Nature Neuroscience,2019,22(3):401-412. [52] XIE C L,ZHUANG X X,NIU Z M,et al.Amelioration of Alzheimer’s disease pathology by mitophagy inducers identified via machine learning and a cross-species workflow[J]. Nature Biomedical Engineering,2022,6(1):76-93. [53] HEUSINKVELD L E,HACKER M L,TURCHAN M,et al.Impact of tremor on patients with early stage Parkinson’s disease[J]. Frontiers in Neurology,2018,9:628. [54] DORSEY E R,SHERER T,MICHAEL S O,et al.The emerging evidence of the Parkinson pandemic[J]. Journal of Parkinson’s Disease,2018,8(s1):S3-S8. [55] ZILOCCHI M,FINZI G,LUALDI M,et al.Mitochondrial alterations in Parkinson’s disease human samples and cellular models[J]. Neurochemistry International,2018,118:61-72. [56] LVCKING C B,ABBAS N,DVRR A,et al.Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism.The European consortium on genetic susceptibility in Parkinson’s disease and the French Parkinson’s disease genetics study group[J]. Lancet (London,England),1998,352(9137):1355-1356. [57] DONG X L,HE X H,YANG L,et al.Inhibition of miR-421 preserves mitochondrial function and protects against Parkinson’s disease pathogenesis via PINK1/Parkin-dependent mitophagy[J]. Disease Markers,2022,2022:5186252. [58] RYAN S D,RYAN T L,BAMM V V,et al.Cardiolipin exposure on the outer mitochondrial membrane modulates α-synuclein proteostasis in Hpsc-derived Parkinson’s disease neurons[J]. The FASEB Journal,2018,59:359. [59] WALTER J,BOLOGNIN S,ANTONY P M A,et al.Neural stem cells of Parkinson’s disease patients exhibit aberrant mitochondrial morphology and functionality[J]. Stem Cell Reports,2019,12(5):878-889. [60] LIZAMA B N,CHU C T.Neuronal autophagy and mitophagy in Parkinson’s disease[J]. Molecular Aspects of Medicine,2021,82:100972. [61] FIEKE W,TOM C,DORIEN I,et al.LRRK2 mutations impair depolarization-induced mitophagy through inhibition of mitochondrial accumulation of RAB10[J]. Autophagy,2020,16(2):203-222. [62] GUEDES-DIAS P,PINHO B R,SOARES T R,et al.Mitochondrial dynamics and quality control in Huntington’s disease[J]. Neurobiology of Disease,2016,90:51-57. [63] NEHA S,HALLIE M,SUDHIR K,et al.Mitochondrial abnormalities and synaptic damage in Huntington’s disease:A focus on defective mitophagy and mitochondria-targeted therapeutics[J]. Molecular Neurobiology,2021,58(12):6350-6377. [64] KHALIL B,FISSI N E,AOUANE A,et al.PINK1-induced mitophagy promotes neuroprotection in Huntington’s disease[J]. Cell Death & Disease,2015,6(1):e1617. [65] SANDRA F I,AINHOA P Z,MARTA M,et al.Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease[J]. Autophagy,2020,17(3):672-689. |